消除宫颈癌：发展中国家面临的挑战。
Elimination of cervical cancer: challenges for developing countries.
作者信息
Beddoe Ann Marie
机构信息
Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
出版信息
Ecancermedicalscience. 2019 Nov 12;13:975. doi: 10.3332/ecancer.2019.975. eCollection 2019.
Abstract
Cervical cancer is one of the most preventable cancers today, yet over 500,000 new cases are diagnosed globally each year and every 2 minutes a woman dies from cervical cancer. The burden of this disease and the highest mortality from cervical cancer occur in developing countries. High-income countries are poised to eliminate cervical cancer in the 21st century, but despite a global call to eliminate this disease, low- and middle-income countries face many challenges as they strive to answer that call.
摘要
宫颈癌是当今最可预防的癌症之一，然而全球每年仍有超过50万例新病例被诊断出来，每两分钟就有一名女性死于宫颈癌。这种疾病的负担以及宫颈癌导致的最高死亡率出现在发展中国家。高收入国家有望在21世纪消除宫颈癌，但尽管全球呼吁消除这种疾病，低收入和中等收入国家在努力响应这一呼吁时仍面临许多挑战。
相似文献
1
Elimination of cervical cancer: challenges for developing countries.消除宫颈癌：发展中国家面临的挑战。
Ecancermedicalscience. 2019 Nov 12;13:975. doi: 10.3332/ecancer.2019.975. eCollection 2019.
2
Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi.宫颈癌筛查——低收入国家完整医疗路径面临的挑战：以马拉维为例
Womens Health (Lond). 2020 Jan-Dec;16:1745506520914804. doi: 10.1177/1745506520914804.
3
Optimizing high risk HPV-based primary screening for cervical cancer in low- and middle-income countries: opportunities and challenges.优化低收入和中等收入国家基于高危型人乳头瘤病毒的宫颈癌初筛：机遇与挑战
Minerva Ginecol. 2019 Oct;71(5):365-371. doi: 10.23736/S0026-4784.19.04468-X.
4
The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries.在50个低收入和中低收入国家扩大宫颈癌预防工作对健康和经济的影响。
Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:47-56. doi: 10.1002/ijgo.12184.
5
Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol.乌干达马尤盖区综合宫颈癌筛查（ASPIRE 马尤盖）：一项实用的序贯集群随机试验方案。
BMC Public Health. 2020 Jan 31;20(1):142. doi: 10.1186/s12889-020-8216-9.
6
Mega Hpv laboratories for cervical cancer control: Challenges and recommendations from a case study of Turkey.用于宫颈癌防控的大型人乳头瘤病毒实验室：来自土耳其案例研究的挑战与建议
Papillomavirus Res. 2019 Jun;7:118-122. doi: 10.1016/j.pvr.2019.03.002. Epub 2019 Mar 13.
7
Human papillomaviruses: The cervical cancer saga in developing countries.人乳头瘤病毒：发展中国家的宫颈癌传奇
J Infect Dev Ctries. 2017 Dec 10;11(11):819-825. doi: 10.3855/jidc.9704.
8
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.人乳头瘤病毒在俄罗斯联邦、前苏联西方国家、高加索地区和中亚的流行情况和型别分布、宫颈癌筛查实践以及疫苗接种实施现状。
Vaccine. 2013 Dec 31;31 Suppl 7:H46-58. doi: 10.1016/j.vaccine.2013.06.043.
9
Innovative approaches to cervical cancer screening in low- and middle-income countries.低收入和中等收入国家宫颈癌筛查的创新方法。
Climacteric. 2018 Jun;21(3):235-238. doi: 10.1080/13697137.2018.1439917. Epub 2018 Feb 28.
10
Epidemiology of cancer of the cervix: global and national perspective.子宫颈癌流行病学：全球及国家视角
J Indian Med Assoc. 2000 Feb;98(2):49-52.
引用本文的文献
1
Barriers and attitudes toward cervical cancer screening among eligible women.符合条件的女性在宫颈癌筛查方面的障碍和态度。
Cancer Causes Control. 2025 Aug 27. doi: 10.1007/s10552-025-02058-4.
2
Syndemic Synergy of HPV, HIV, and HSV-2 for Oncogenic HPV Replication in Female Sex Workers.人乳头瘤病毒、艾滋病毒和单纯疱疹病毒2型在女性性工作者中对致癌性人乳头瘤病毒复制的综合征协同作用
Trop Med Infect Dis. 2025 Jun 7;10(6):157. doi: 10.3390/tropicalmed10060157.
3
Awareness about cervical cancer and its socio-economic determinants among adults in Bangladesh: Results from a nationwide cross-sectional study.孟加拉国成年人对宫颈癌及其社会经济决定因素的认知：一项全国性横断面研究的结果
PLoS One. 2025 Jun 10;20(6):e0325712. doi: 10.1371/journal.pone.0325712. eCollection 2025.
4
Prevalence and determinants of cervical cancer screening among women aged 15-49 years in Tanzania: analysis of demographic and health survey 2022.坦桑尼亚15至49岁女性宫颈癌筛查的患病率及决定因素：2022年人口与健康调查分析
Arch Public Health. 2025 May 23;83(1):135. doi: 10.1186/s13690-025-01629-w.
5
Client perspectives and satisfaction with integrating facility and community-based HPV self-sampling for cervical cancer screening with family planning: a mixed method study.客户对将基于机构和社区的人乳头瘤病毒（HPV）自我采样与计划生育相结合进行宫颈癌筛查的看法及满意度：一项混合方法研究
BMC Public Health. 2025 May 9;25(1):1718. doi: 10.1186/s12889-025-22761-w.
6
Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are still demanded.针对人乳头瘤病毒（HPV）引发的宫颈癌的预防性疫苗：仍需要新型疫苗。
Infect Agent Cancer. 2025 Mar 10;20(1):16. doi: 10.1186/s13027-025-00643-5.
7
Self-Collection for HPV-Based Cervical Screening: Knowledge and Attitudes of Australian Health Care Workers in an Area With Low Screening Rates, July-November 2023.基于人乳头瘤病毒的宫颈癌筛查自我采样：2023年7月至11月澳大利亚低筛查率地区医护人员的知识与态度
Public Health Rep. 2024 Dec 12:333549241299272. doi: 10.1177/00333549241299272.
8
Leishmania tarentolae as a platform for the production of vaccines against viral pathogens.地中海利什曼原虫作为生产抗病毒病原体疫苗的平台。
NPJ Vaccines. 2024 Nov 6;9(1):212. doi: 10.1038/s41541-024-01005-9.
9
Knowledge, Attitude and Practice Concerning Cervical Cancer Screening Among Reproductive Age Group Women in Low-Resource Settings Yenagoa Bayelsa State.低资源环境下耶那戈阿州巴耶尔萨州育龄妇女宫颈癌筛查的知识、态度和实践情况
Niger Med J. 2024 Sep 26;65(4):512-523. doi: 10.60787/nmj-v65i3-492. eCollection 2024 Jul-Aug.
10
GSK3B inhibition reduced cervical cancer cell proliferation and migration by modulating the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.GSK3B 抑制通过调节 PI3K/Akt 信号通路和上皮间质转化来减少宫颈癌细胞的增殖和迁移。
Braz J Med Biol Res. 2024 Aug 19;57:e13796. doi: 10.1590/1414-431X2024e13796. eCollection 2024.
本文引用的文献
1
HPV vaccination coverage and course completion rates for Indigenous Australian adolescents, 2015.HPV 疫苗接种覆盖率和完成率在澳大利亚原住民青少年中，2015 年。
Med J Aust. 2019 Jul;211(1):31-36. doi: 10.5694/mja2.50221. Epub 2019 Jun 9.
2
Cancer statistics, 2019.癌症统计数据，2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
3
The projected timeframe until cervical cancer elimination in Australia: a modelling study.澳大利亚消除宫颈癌的预计时间框架：建模研究。
Lancet Public Health. 2019 Jan;4(1):e19-e27. doi: 10.1016/S2468-2667(18)30183-X. Epub 2018 Oct 2.
4
Modelling cervical cancer elimination.模拟消除宫颈癌
Lancet Public Health. 2019 Jan;4(1):e2-e3. doi: 10.1016/S2468-2667(18)30189-0. Epub 2018 Oct 2.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018：GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
Prevention of Cervical Cancer in Sub-Saharan Africa: The Advantages and Challenges of HPV Vaccination.撒哈拉以南非洲地区宫颈癌的预防：人乳头瘤病毒疫苗接种的优势与挑战
Vaccines (Basel). 2018 Sep 8;6(3):61. doi: 10.3390/vaccines6030061.
7
Evaluation of human-papillomavirus testing and visual inspection for cervical cancer screening in Rwanda.卢旺达宫颈癌筛查中人乳头瘤病毒检测与肉眼检查的评估
BMC Womens Health. 2018 Apr 24;18(1):59. doi: 10.1186/s12905-018-0549-5.
8
Explanations for the high potency of HPV prophylactic vaccines.HPV 预防性疫苗高效力的解释。
Vaccine. 2018 Aug 6;36(32 Pt A):4768-4773. doi: 10.1016/j.vaccine.2017.12.079. Epub 2018 Jan 8.
9
Ethnic and racial disparities in cervical cancer: lessons from a modelling study of cervical cancer prevention.宫颈癌中的种族差异：一项宫颈癌预防模型研究的经验教训。
Lancet Public Health. 2018 Jan;3(1):e8-e9. doi: 10.1016/S2468-2667(17)30233-5. Epub 2017 Dec 19.
10
Effect of HPV vaccination and cervical cancer screening in England by ethnicity: a modelling study.英格兰按种族划分的 HPV 疫苗接种和宫颈癌筛查效果：建模研究。
Lancet Public Health. 2018 Jan;3(1):e44-e51. doi: 10.1016/S2468-2667(17)30238-4. Epub 2017 Dec 19.
Zotero 插件